{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:52:52Z","timestamp":1791337972774,"version":"4.3.1"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.1001\/jamaneurol.2021.4584","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T16:02:19Z","timestamp":1639411339000},"page":"169","source":"Crossref","is-referenced-by-count":47,"title":["Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy"],"prefix":"10.1001","volume":"79","author":[{"given":"David","family":"Larsson","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arton","family":"Baftiu","sequence":"additional","affiliation":[{"name":"Program for Pharmacy, Oslo Metropolitan University, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Johannessen Landmark","sequence":"additional","affiliation":[{"name":"Program for Pharmacy, Oslo Metropolitan University, Oslo, Norway"},{"name":"The National Center for Epilepsy, Oslo University Hospital, Oslo, Norway"},{"name":"Section for Clinical Pharmacology, Department of Pharmacology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"von Euler","sequence":"additional","affiliation":[{"name":"Department of Neurology, Faculty of Medicine and Health, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kumlien","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signild","family":"\u00c5sberg","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Zelano","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"noi210079r1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/ene.2005.12.issue-4","article-title":"The epidemiology of epilepsy in Europe\u2014a systematic review.","volume":"12","author":"Forsgren","year":"2005","journal-title":"Eur J Neurol"},{"issue":"8","key":"noi210079r2","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00415-018-8907-7","article-title":"The occurrence of seizures after ischemic stroke does not influence long-term mortality; a 26-year follow-up study.","volume":"265","author":"van Tuijl","year":"2018","journal-title":"J Neurol"},{"issue":"8","key":"noi210079r3","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1161\/STROKEAHA.115.010115","article-title":"Poststroke epilepsy is associated with a high mortality after a stroke at young age: follow-up of Transient Ischemic Attack and Stroke Patients and Unelucidated Risk Factor Evaluation study.","volume":"46","author":"Arntz","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"noi210079r4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/2396987316669000","article-title":"Association between poststroke epilepsy and death: a nationwide cohort study.","volume":"1","author":"Zelano","year":"2016","journal-title":"Eur Stroke J"},{"key":"noi210079r5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.eplepsyres.2015.03.002","article-title":"Antiepileptic drug use for treatment of epilepsy and dyslipidemia: systematic review.","volume":"113","author":"Vyas","year":"2015","journal-title":"Epilepsy Res"},{"key":"noi210079r6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2016.02.013","article-title":"Challenges in the pharmacological management of epilepsy and its causes in the elderly.","volume":"106","author":"Ferlazzo","year":"2016","journal-title":"Pharmacol Res"},{"issue":"10","key":"noi210079r7","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/epi.14554","article-title":"Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.","volume":"59","author":"Mintzer","year":"2018","journal-title":"Epilepsia"},{"issue":"1","key":"noi210079r8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/epi4.v6.1","article-title":"FDA safety warning on the cardiac effects of lamotrigine: an advisory from the Ad Hoc ILAE\/AES Task Force.","volume":"6","author":"French","year":"2021","journal-title":"Epilepsia Open"},{"issue":"2","key":"noi210079r9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1747-4949.2010.00557.x","article-title":"The Riks-Stroke story: building a sustainable national register for quality assessment of stroke care.","volume":"6","author":"Asplund","year":"2011","journal-title":"Int J Stroke"},{"key":"noi210079r11","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish National Inpatient Register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"7","key":"noi210079r12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/(ISSN)1099-1557","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"noi210079r13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register.","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"noi210079r14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.seizure.2018.11.013","article-title":"Retention rate of first antiepileptic drug in poststroke epilepsy: a nationwide study.","volume":"64","author":"Larsson","year":"2019","journal-title":"Seizure"},{"issue":"4","key":"noi210079r15","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/01.STR.0000260102.97954.9c","article-title":"Assessment of functional outcome in a national quality register for acute stroke: can simple self-reported items be transformed into the modified Rankin Scale?","volume":"38","author":"Eriksson","year":"2007","journal-title":"Stroke"},{"issue":"7","key":"noi210079r16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/epi.v61.7","article-title":"The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies.","volume":"61","author":"Mbizvo","year":"2020","journal-title":"Epilepsia"},{"issue":"1","key":"noi210079r17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"issue":"4","key":"noi210079r18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein.","volume":"65","author":"Mintzer","year":"2009","journal-title":"Ann Neurol"},{"issue":"1-2","key":"noi210079r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment.","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res"},{"issue":"1","key":"noi210079r20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/epi.2011.53.issue-1","article-title":"Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.","volume":"53","author":"Chuang","year":"2012","journal-title":"Epilepsia"},{"issue":"9","key":"noi210079r21","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/pds.2186","article-title":"Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study.","volume":"20","author":"Olesen","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"noi210079r22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/heartjnl-2014-305664","article-title":"Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications.","volume":"101","author":"Bardai","year":"2015","journal-title":"Heart"},{"issue":"8","key":"noi210079r23","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/epi.2009.50.issue-8","article-title":"Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine.","volume":"50","author":"Saetre","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"noi210079r24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40266-021-00837-7","article-title":"Seizures and epilepsy after stroke: epidemiology, biomarkers and management.","volume":"38","author":"Galovic","year":"2021","journal-title":"Drugs Aging"},{"key":"noi210079r25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.seizure.2015.06.016","article-title":"Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study.","volume":"31","author":"Bruun","year":"2015","journal-title":"Seizure"},{"issue":"12","key":"noi210079r26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032551","article-title":"Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records.","volume":"9","author":"Powell","year":"2019","journal-title":"BMJ Open"},{"issue":"2","key":"noi210079r27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1212\/WNL.0000000000004094","article-title":"The incidence of SUDEP: a nationwide population-based cohort study.","volume":"89","author":"Sveinsson","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"noi210079r28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/STROKEAHA.111.000220","article-title":"Incidence and associations of poststroke epilepsy: the prospective South London Stroke Register.","volume":"44","author":"Graham","year":"2013","journal-title":"Stroke"},{"issue":"6","key":"noi210079r29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/ane.12070","article-title":"Incidence and predictors of post-stroke epilepsy.","volume":"127","author":"Jungehulsing","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"noi210079r30","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1177\/1403494813499653","article-title":"Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden.","volume":"41","author":"Eriksson","year":"2013","journal-title":"Scand J Public Health"},{"issue":"1","key":"noi210079r31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1590\/0004-282x-anp-2020-0012","article-title":"Trends in prescribing patterns of antiepileptic drugs among older adult inpatients in a Brazilian tertiary center.","volume":"79","author":"Assis","year":"2021","journal-title":"Arq Neuropsiquiatr"},{"key":"noi210079r10","unstructured":"Riksstroke. Evaluations of variables in Riksstroke, the Swedish Stroke Register: short version in English. Accessed November 2, 2021. https:\/\/www.riksstroke.org\/wp-content\/uploads\/2015\/06\/Evaluations-of-variables-in-Riksstroke-rev-15-08-03.pdf"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2786668\/jamaneurology_larsson_2021_oi_210079_1644604377.07687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T17:48:22Z","timestamp":1644860902000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2786668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.4584","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}